Anti-VEGF for the Management of Diabetic Macular Edema

Anti-VEGF for the Management of Diabetic Macular Edema

Diabetic retinopathy (DR) is an important cause of vision loss around the world, being the leading cause in the population between 20 and 60 years old. Among patients with DR, diabetic macular edema (DME) is the most frequent cause of vision impairment and represents a significant public health issu...

Full description

Saved in:
Bibliographic Details
Main Authors: Francisco Rosa Stefanini, Emmerson Badaró, Paulo Falabella, Michael Koss, Michel Eid Farah, Maurício Maia
Format: Article
Language:English
Published: Wiley 2014-01-01
Series:Journal of Immunology Research
Online Access:http://dx.doi.org/10.1155/2014/632307
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items